Search research articles
Contact Us
Filters
Showing results (1-10 of 75) with videos related to
Page
of 8
Sort By:
Scientific Reports
|
June 12, 2024
Real-life effectiveness of sacubitril/valsartan in older Belgians with heart failure, reduced ejection fraction and most severe symptoms
Eléonore Maury, Ann Belmans, Kris Bogaerts, et al.
Circulation
|
November 25, 2010
Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium
Philip Moons, Lore Bovijn, Werner Budts, et al.
Pharmacoepidemiology and Drug Safety
|
December 13, 2005
Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin
Bernard Vrijens, Ann Belmans, Katelijne Matthys, et al.
Clinical Orthopaedics and Related Research
|
August 5, 2021
Ninety-Day Follow-up Is Inadequate for Diagnosis of Fracture-related Infections in Patients with Open Fractures
Charalampos G Zalavras, Laurens Aerden, Peter Declercq, et al.
Drugs & Aging
|
November 20, 2025
Effectiveness of Sacubitril/Valsartan in Reducing Hospitalizations in Older Belgian Adults with Heart Failure and Reduced Ejection Fraction: An Age-Stratified Study
Eléonore Maury, Lorenz Van der Linden, Kris Bogaerts, et al.
Acta Cardiologica
|
July 8, 2017
Introducing ICD-resistant mortality as an end point to evaluate the clinical efficacy of an implantable cardioverter-defibrillator in ischaemic cardiomyopathy
Vincent Floré, Bert Vandenberk, Ann Belmans, et al.
European Journal of Anaesthesiology
|
September 14, 2020
Patient satisfaction with intravenous regional anaesthesia or an axillary block for minor ambulatory hand surgery: A randomised controlled study
An Teunkens, Kristien Vermeulen, Ann Belmans, et al.
Trials
|
February 10, 2021
Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial
Iwein Gyselinck, Laurens Liesenborghs, Ewout Landeloos, et al.
Trials
|
March 6, 2021
Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial
Iwein Gyselinck, Laurens Liesenborghs, Ewout Landeloos, et al.
The American Journal of Cardiology
|
December 26, 2007
Results of percutaneous coronary intervention of the unprotected left main coronary artery in 143 patients and comparison of 30-day mortality to results of coronary artery bypass grafting
Christophe Dubois, Joseph Dens, Peter Sinnaeve, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 75) with videos related to
Sort By:
Page
of 8
Scientific Reports
|
June 12, 2024
Real-life effectiveness of sacubitril/valsartan in older Belgians with heart failure, reduced ejection fraction and most severe symptoms
Eléonore Maury, Ann Belmans, Kris Bogaerts, et al.
Circulation
|
November 25, 2010
Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium
Philip Moons, Lore Bovijn, Werner Budts, et al.
Pharmacoepidemiology and Drug Safety
|
December 13, 2005
Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin
Bernard Vrijens, Ann Belmans, Katelijne Matthys, et al.
Clinical Orthopaedics and Related Research
|
August 5, 2021
Ninety-Day Follow-up Is Inadequate for Diagnosis of Fracture-related Infections in Patients with Open Fractures
Charalampos G Zalavras, Laurens Aerden, Peter Declercq, et al.
Drugs & Aging
|
November 20, 2025
Effectiveness of Sacubitril/Valsartan in Reducing Hospitalizations in Older Belgian Adults with Heart Failure and Reduced Ejection Fraction: An Age-Stratified Study
Eléonore Maury, Lorenz Van der Linden, Kris Bogaerts, et al.
Acta Cardiologica
|
July 8, 2017
Introducing ICD-resistant mortality as an end point to evaluate the clinical efficacy of an implantable cardioverter-defibrillator in ischaemic cardiomyopathy
Vincent Floré, Bert Vandenberk, Ann Belmans, et al.
European Journal of Anaesthesiology
|
September 14, 2020
Patient satisfaction with intravenous regional anaesthesia or an axillary block for minor ambulatory hand surgery: A randomised controlled study
An Teunkens, Kristien Vermeulen, Ann Belmans, et al.
Trials
|
February 10, 2021
Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial
Iwein Gyselinck, Laurens Liesenborghs, Ewout Landeloos, et al.
Trials
|
March 6, 2021
Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial
Iwein Gyselinck, Laurens Liesenborghs, Ewout Landeloos, et al.
The American Journal of Cardiology
|
December 26, 2007
Results of percutaneous coronary intervention of the unprotected left main coronary artery in 143 patients and comparison of 30-day mortality to results of coronary artery bypass grafting
Christophe Dubois, Joseph Dens, Peter Sinnaeve, et al.
Page
of 8